瓦博格效应
厌氧糖酵解
间质细胞
生物
癌变
癌细胞
糖酵解
基质
细胞生物学
癌相关成纤维细胞
肿瘤微环境
癌症研究
癌症
肿瘤进展
生物化学
免疫学
新陈代谢
免疫组织化学
遗传学
作者
Stephanos Pavlides,Diana Whitaker‐Menezes,Remedios Castelló-Cros,Neal Flomenberg,Agnieszka K. Witkiewicz,Philippe G. Frank,Mathew C. Casimiro,Chenguang Wang,Paolo Fortina,Sankar Addya,Richard G. Pestell,Ubaldo Martinez‐Outschoorn,Federica Sotgia,Michael P. Lisanti
出处
期刊:Cell Cycle
[Informa]
日期:2009-12-01
卷期号:8 (23): 3984-4001
被引量:1207
标识
DOI:10.4161/cc.8.23.10238
摘要
Here, we propose a new model for understanding the Warburg effect in tumor metabolism. Our hypothesis is that epithelial cancer cells induce the Warburg effect (aerobic glycolysis) in neighboring stromal fibroblasts. These cancer-associated fibroblasts, then undergo myo-fibroblastic differentiation, and secrete lactate and pyruvate (energy metabolites resulting from aerobic glycolysis). Epithelial cancer cells could then take up these energy-rich metabolites and use them in the mitochondrial TCA cycle, thereby promoting efficient energy production (ATP generation via oxidative phosphorylation), resulting in a higher proliferative capacity. In this alternative model of tumorigenesis, the epithelial cancer cells instruct the normal stroma to transform into a wound-healing stroma, providing the necessary energy-rich micro-environment for facilitating tumor growth and angiogenesis. In essence, the fibroblastic tumor stroma would directly feed the epithelial cancer cells, in a type of host-parasite relationship. We have termed this new idea the "Reverse Warburg Effect." In this scenario, the epithelial tumor cells "corrupt" the normal stroma, turning it into a factory for the production of energy-rich metabolites. This alternative model is still consistent with Warburg's original observation that tumors show a metabolic shift towards aerobic glycolysis. In support of this idea, unbiased proteomic analysis and transcriptional profiling of a new model of cancer-associated fibroblasts (caveolin-1 (Cav-1) deficient stromal cells), shows the up-regulation of both i) myo-fibroblast markers and ii) glycolytic enzymes, under normoxic conditions. We validated the expression of these proteins in the fibroblastic stroma of human breast cancer tissues that lack stromal Cav-1. Importantly, a loss of stromal Cav-1 in human breast cancers is associated with tumor recurrence, metastasis, and poor clinical outcome. Thus, an absence of stromal Cav-1 may be a biomarker for the "Reverse Warburg Effect", explaining its powerful predictive value.
科研通智能强力驱动
Strongly Powered by AbleSci AI